Science and the corporation: good bad and ugly
the Scientist announces an upcoming workshop titled From Bench to Boardroom: a Workshop on the Commercialization of Research,
including sessions on how to start a company. It will take place
on April 17 in Washington, DC. However, some may also want to
look at a recent New York Review article, the Dawn of McScience,
by physician and Lancet editor Richard Horton. Reviewing a recent
book, Science in the Private Interest: Has the Lure of Profits
Corrupted Biomedical Research, by Sheldon Krimsky, he laments several
high-profile cases of corporations sponsoring research and influencing
and even surpressing unfavorable results. (On the other hand, as
editor of a journal whose publisher charges close to a hundred grand
for the Lancet backfiles, maybe he should look closer to home.)
